Skip to content
Collagen & skincollagen peptides

Collagen Peptides: What the Human Trials Found

Hydrolyzed collagen has real human trials behind it. The effect sizes for skin and joints, the doses used, who funded the studies, and what is still open.

The short version

Collagen peptides are broken-down collagen sold as a supplement. They are legal to buy and have a real body of human trials behind them, mostly on skin and joint measures. The effects are modest and much of the research is industry-funded. This is a different category from injectable research peptides.

  • A dietary supplement, not a research chemical.
  • Human data exists mainly for some skin and joint endpoints.
  • Read labels and claims carefully, because “collagen” products are not all equal.

Collagen peptides are the most-studied supplement I cover. There are real randomized trials. But the effect sizes are modest, much of the authorship traces to one research institute, and several claims that circulate everywhere are supported nowhere I could find.

US legal status - Dietary supplement

Regulated as a dietary supplement in the US. Supplements are not FDA-approved; manufacturers are responsible for their own safety and labelling, and the FDA acts only after a problem surfaces.

What hydrolyzed collagen is

Collagen peptides and hydrolyzed collagen are the same thing: collagen protein enzymatically broken into short peptide fragments. Labels quote molecular weight ranges with great confidence. I am not repeating a specific range, because no source I checked establishes that any quoted range characterizes what is in marketed products.

Collagen types are tissue-specific (León-López 2019 - León-López A, Morales-Peñaloza A, Martínez-Juárez VM et al. Hydrolyzed Collagen-Sources and Applications. Molecules. 2019;24(22)., in the references below):

  • Type I predominates in skin, bone, teeth, tendon, ligaments and vasculature.
  • Type II is the cartilage collagen.
  • Type III is common in skin, muscle and blood vessels.

Does it survive digestion?

Partly, and that “partly” is the whole story.

Digestion should in principle reduce collagen to amino acids like any other protein, making it an expensive source of glycine and proline. But some collagen-derived peptides do appear intact in blood. Sato 2017 - Sato K. The presence of food-derived collagen peptides in human body-structure and biological activity. Food Funct. 2017;8(12):4325-4330., in the references below reports that “micromolar levels of food-derived collagen peptides are present in human blood.” Most bioactive food peptides sit at nanomolar levels. The dipeptide Pro-Hyp (proline-hydroxyproline) is the best-characterized. The same review reports it “enhances the growth of fibroblasts and synthesis of hyaluronic acid.”

The review adds two qualifications. The fibroblast and hyaluronic acid activity is in vitro: cells in a dish, not skin on a person. And the author says these observations only “partially explain” the benefits of ingesting collagen hydrolysate. The author of the mechanistic case is saying it is incomplete.

How collagen compares with other peptides taken by mouth: oral peptides. Capsules and tablets against powder, dose for dose: collagen pills vs powder.

Skin: the strongest case, and it is getting more tempered

Moderate human evidence

Multiple randomised trials, though with limitations. Two meta-analyses of 19 randomized trials each, but the effect sizes are small, the two syntheses disagree about elasticity, and several flagship trials share authors affiliated with a collagen research institute.

Skin is where the evidence is deepest, and where the trend line is worth watching.

de 2021 - de Miranda RB, Weimer P, Rossi RC. Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis. Int J Dermatol. 2021;60(12):1449-1461., in the references below pooled 19 double-blind randomized trials covering 1,125 participants (95% female, aged 20–70). Its conclusion: “ingestion of hydrolyzed collagen for 90 days is effective in reducing skin aging, as it reduces wrinkles and improves skin elasticity and hydration.” Most collagen marketing is built on that sentence.

Nukaly 2026 - Nukaly HY, Halawani IR, Irtaza HM et al. Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). 2026;13:1618306., in the references below, also of 19 randomized trials but covering 1,341 participants, is more restrained. It found only “a modest pooled effect on wrinkle reduction (MD = 0.27, p = 0.04),” while “effects on elasticity and density were inconsistent.” It called for “larger RCTs with standardized outcomes and histopathologic assessment.”

Elasticity was the older literature’s headline finding, and the newer synthesis calls it inconsistent. I do not know why. Better risk-of-bias handling, newer null trials and different inclusion criteria are all possible. Until someone establishes the reason, that disagreement is the most important fact on this page about skin. The comparison is my editorial framing, not a claim of either paper.

A frequently cited individual trial is Proksch 2014 - Proksch E, Segger D, Degwert J et al. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study. Skin Pharmacol Physiol. 2014;27(1):47-55., in the references below. It randomized 69 women aged 35–55 to 2.5 g collagen hydrolysate, 5.0 g, or placebo (23 per group) for 8 weeks, with a 4-week follow-up. Elasticity improved significantly in both collagen groups versus placebo. Moisture and transepidermal water loss showed positive trends but did not reach significance overall. Co-authors S. Oesser and M. Schunck are affiliated with CRI, Collagen Research Institute, Kiel.

Joints: two different products that must not be blended

Blending the two products below is the most common error in collagen marketing.

Hydrolyzed collagen, around 10 g/day

Limited human data

Small or uncontrolled human studies. Too little to settle the question either way. One 24-week trial in athletes with joint pain (97 of 147 enrolled were analyzed) plus a 2018 meta-analysis that found a large short-term pain effect but rated the quality of evidence very low and found nothing clinically important at medium or long term.

Clark 2008 - Clark KL, Sebastianelli W, Flechsenhar KR et al. 24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain. Curr Med Res Opin. 2008;24(5):1485-96., in the references below gave 10 g/day of collagen hydrolysate for 24 weeks to athletes with activity-related joint pain. 147 were enrolled and 97 were analyzed. Roughly 34% dropped out, which is a lot. Physician-assessed joint pain at rest and five patient-reported pain measures improved significantly versus placebo. The effect was more pronounced in the knee-pain subgroup (n=63). That is a subgroup analysis, so read it as hypothesis-generating. The lead author was at Penn State. No funding statement is visible on the PubMed record, which is not evidence of independence either way.

The skeptical anchor is Liu 2018 - Liu X, Machado GC, Eyles JP et al. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. Br J Sports Med. 2018;52(3):167-175., in the references below, which assessed 20 supplements across 69 studies. Collagen hydrolysate was among the supplements with “large (effect size >0.80) and clinically important effects for pain reduction at short term.” The same abstract says the quality of that evidence was “very low,” and that the supplements “had no clinically important effects on pain and function at medium-term and long-term follow-ups.” It also found glucosamine and chondroitin either ineffective or of arguably clinically unimportant effect.

A large effect built on very low quality evidence that disappears past the short term calls for better trials, not purchases.

UC-II is not hydrolyzed collagen

Limited human data

Small or uncontrolled human studies. Too little to settle the question either way. One pivotal 180-day trial in 191 people with knee osteoarthritis, sponsored by the ingredient manufacturer and authored partly by its employees. The proposed oral-tolerance mechanism is not confirmed in humans.

Undenatured type II collagen (UC-II) is a genuinely different intervention:

  • Dose: 40 mg/day, versus about 10 g/day for hydrolysate, which is roughly 250 times smaller.
  • Proposed mechanism: oral tolerance and immune modulation, not supplying raw material. Researchers propose it teaches the immune system not to attack joint cartilage. I could not confirm that this operates in humans rather than being inferred from animal work.

The pivotal trial is Lugo 2016 - Lugo JP, Saiyed ZM, Lane NE. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study. Nutr J. 2016;15:14., in the references below. It randomized 191 subjects with knee osteoarthritis (not healthy volunteers) for 180 days to UC-II 40 mg, glucosamine 1500 mg plus chondroitin 1200 mg, or placebo. Total WOMAC score improved versus placebo (p=0.002) and versus glucosamine/chondroitin (p=0.04).

The trial was manufacturer-sponsored, and two of three authors were employed by the ingredient company. But it would be wrong to call it manufacturer-run. Its competing-interests disclosure states a contract research organization ran and managed the study independently, site staff collected the data, and an independent statistician did the analysis.

Bone: essentially one trial

Limited human data

Small or uncontrolled human studies. Too little to settle the question either way. A single 12-month randomized trial in 131 postmenopausal women. The absolute T-score changes are small and the standard deviations exceed the mean effects. No independent replication surfaced.

König 2018 - König D, Oesser S, Scharla S et al. Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women-A Randomized Controlled Study. Nutrients. 2018;10(1)., in the references below gave 5 g/day of specific collagen peptides or placebo to 131 postmenopausal women for 12 months (102 completers; mean age 64.3). Spine T-score changed by +0.1 ± 0.26 versus −0.03 ± 0.18 for placebo (p=0.030). Femoral neck changed by +0.09 ± 0.24 versus −0.01 ± 0.19 (p=0.003).

Look past the p-values. The absolute changes are small, and the standard deviations are larger than the mean effects. This is one trial, and I could not find an independent, adequately powered replication.

The placebo was maltodextrin. The trial’s methods specify “5 g SCP or placebo (maltodextrin, CARGILL, Paris, France)” (König 2018 - König D, Oesser S, Scharla S et al. Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women-A Randomized Controlled Study. Nutrients. 2018;10(1)., in the references below). This next point is my own analysis, not a finding of the paper. No trial I found compares collagen against an isonitrogenous protein control, so it is unestablished whether the effect is specific to collagen or comes from 5 g of any protein.

Hair and nails: the thin end

Limited human data

Small or uncontrolled human studies. Too little to settle the question either way. Nails: one open-label study in 25 people with no control or placebo group. Placebo response, regression to the mean and natural variation cannot be excluded.

For nails, the study everyone cites is Hexsel 2017 - Hexsel D, Zague V, Schunck M et al. Oral supplementation with specific bioactive collagen peptides improves nail growth and reduces symptoms of brittle nails. J Cosmet Dermatol. 2017;16(4):520-526., in the references below: 25 participants, 2.5 g/day of a specific collagen peptide for 24 weeks. It reported a 12% increase in nail growth rate, 42% fewer broken nails, and 64% global clinical improvement.

The part that rarely makes the marketing: the study was open-label with no control or placebo group. Everyone knew what they were taking and there was nothing to compare against. Placebo response, regression to the mean and the natural variation of nail growth cannot be excluded. The tested ingredient was a bioactive collagen peptide (VERISOL), and a Collagen Research Institute researcher is a co-author.

Limited human data

Small or uncontrolled human studies. Too little to settle the question either way. One 24-week placebo-controlled trial in 114 women measured hair thickness, not hair count or regrowth. It tested one product and has not been repeated.

For hair, one trial has a hair endpoint. In it, 114 women with self-reported thinning took a fish collagen peptide or placebo for 24 weeks. Hair diameter increased significantly on collagen, and more women on collagen than on placebo showed measurable thickening. Hwang 2026 - Hwang S, Won J, Kim S et al. Low-Molecular-Weight Collagen Peptide Supplementation Improves Cellulite Severity, Skin Elasticity, and Hair Shaft Diameter: A Clinical Study with Pharmacokinetic Evaluation. J Med Food. 2026;29(4):187-195., in the references below It measured how thick each hair was, not how many grew, and I found no second trial. If a product’s main pitch is regrowth, that pitch has no trial behind it. More: peptides for hair growth.

Bovine, marine, porcine: does the source matter?

I do not know, and the confident answer you have read elsewhere appears to be unsourced.

León-López 2019 - León-López A, Morales-Peñaloza A, Martínez-Juárez VM et al. Hydrolyzed Collagen-Sources and Applications. Molecules. 2019;24(22)., in the references below names bovine, porcine, ovine, chicken, duck, rabbit, fish and jellyfish as sources of hydrolyzed collagen. The widely repeated shorthand is that marine is type I, bovine is types I and III, and chicken is type II. It is routinely attributed to that same review, and it is not in the paper. In the full text, “UC-II,” “undenatured” and “sternum” appear zero times, and chicken appears only as a raw material. The review does the tissue-level typing above and names the species. It does not connect the two into a species-to-type map.

That shorthand may well be true. But I could not find a primary source for it, and no head-to-head human trial of marine versus bovine surfaced in my searches. I have not investigated whether sourcing risks (BSE-prion considerations for bovine, allergen risk for marine) differ materially by species. Anyone selling you marine collagen on a type argument is selling an argument they have not sourced either.

Does molecular weight actually matter?

Probably less than the label implies, and nobody has cleanly tested it.

The marketing logic is that smaller peptides absorb better, so lower daltons must mean better results. Two pieces of human evidence bear on it, and neither delivers.

Sugihara 2018 - Sugihara F, Inoue N, Venkateswarathirukumara S. Ingestion of bioactive collagen hydrolysates enhanced pressure ulcer healing in a randomized double-blind placebo-controlled clinical study. Sci Rep. 2018;8(1):11403., in the references below randomized 120 subjects (112 completers) with stage II/III pressure ulcers to a hydrolysate of mean molecular weight 5,000 Da, one of 1,200 Da, or placebo. The lower-molecular-weight arm beat placebo on all three endpoints. The higher one beat placebo on PUSH score only. That sounds like a win for small peptides until you notice two things:

  • The arms were never compared head-to-head.
  • Molecular weight was confounded with dipeptide content, because the arms differ in both at once.

Molecular weight cannot be isolated as the cause. It is also a wound-healing population, not a cosmetic or joint one.

Iwasaki 2022 - Iwasaki Y, Nakatogawa M, Shimizu A et al. Comparison of gelatin and low-molecular weight gelatin hydrolysate ingestion on hydroxyproline (Hyp), Pro-Hyp and Hyp-Gly concentrations in human blood. Food Chem. 2022;369:130869., in the references below, a pharmacokinetic study in nine people, found that low-molecular-weight gelatin hydrolysate significantly raised plasma Pro-Hyp and Hyp-Gly compared with gelatin. But ordinary gelatin hydrolysate did not significantly exceed plain gelatin on Hyp-Gly Cmax or AUC. The authors concluded that “gelatin is useful as a functional food as effectively as GH.” No collagen brand will put that on a box.

Doses and durations that were actually studied

This describes the literature. It is not a dosing recommendation.

OutcomeDose studiedDurationCaveat
Skin2.5–5 g/day in the trials I verified (up to ~10 g/day reported elsewhere)8–12 weeks; meta-analyses emphasize ~90 daysModest; elasticity now called inconsistent
Joints (hydrolysate)~10 g/day24 weeks~34% attrition; quality very low
Joints (UC-II)40 mg/day180 daysOne sponsor-authored trial
Bone5 g/day12 monthsOne trial; SDs exceed effects
Nails2.5 g/day24 weeksUncontrolled, n=25
Hair1 g/day (fish collagen peptide)24 weeksOne trial; measured thickness, not hair count

What a skeptical reviewer would say

A critical reviewer would make five points about this literature. I think all five land.

  1. The pooling may be doing the work. Meta-analyses combine heterogeneous proprietary “specific collagen peptides” across brands, doses, sources and molecular weights. It is unanswered whether that is one coherent intervention or whether the pooling manufactures apparent consistency.
  2. The control is wrong. Maltodextrin is not a protein. Without an isonitrogenous control, a trial cannot distinguish “collagen works” from “5 g of protein works.”
  3. The mechanism stops at the bloodstream. Peptides in plasma, fibroblast effects in a dish, and an author saying his own findings only “partially explain” the results add up to a mechanism sketch, not a mechanism.
  4. The best joint result is very low quality by the meta-analysts’ own grading, and it vanishes past the short term.
  5. The author list repeats. The next section covers that.

The funding and authorship pattern

This section is descriptive. I am not alleging bias or misconduct, and none of it means the findings are wrong.

Steffen Oesser, affiliated with “CRI, Collagen Research Institute GmbH” (Kiel, Germany), is a co-author on three flagship studies, which are the three pillars of the consumer case:

The affiliation is verifiable on the bone trial’s author affiliations. M. Schunck, also CRI-affiliated, appears on both the skin trial and the nail study.

Three studies underwriting three different product claims share authors from one institute whose subject is collagen. Weigh that however you like. I would rather you knew.

How to choose

The sensible criteria are unglamorous:

  • Decide what you are buying it for. Skin has the most support, and it is modest. Everything else is thinner.
  • Match the studied dose to the studied outcome. 2.5–5 g/day for skin; ~10 g/day is what joint trials used. If you want UC-II, buy UC-II at 40 mg, not a hydrolysate powder quoting UC-II research.
  • Ignore molecular weight marketing until a head-to-head trial isolates it.
  • Ignore species-type arguments until someone sources them.
  • Give it the studied duration. Meta-analyses emphasize ~90 days for skin. Judging at three weeks tells you nothing.
  • Do not pay for an “FDA-registered facility” claim. Third-party testing is worth having, but it addresses purity, not efficacy. Neither is evidence that the product does anything.

My current picks, with doses, testing and prices as of 3 October 2026, are on the best collagen supplement page.

Collagen peptides are among the few supplements with a genuine randomized-trial literature behind them, and a case study in how a modest, contested effect gets marketed as a settled one. Skin is the only area with a real body of evidence, and the trials there ran 2.5–5 g/day for around 90 days. That is what was studied, and I am not going to inflate it.

Common questions

Do collagen peptides actually work for skin?

Skin is the strongest area, but the effect is modest and the picture is not settled. A 2021 meta-analysis of 19 randomized trials in 1,125 people concluded that 90 days of hydrolyzed collagen reduces wrinkles and improves elasticity and hydration. A 2026 meta-analysis of 19 trials in 1,341 people was more cautious. It found a modest pooled effect on wrinkle reduction, with effects on elasticity and density described as inconsistent. Several flagship trials were co-authored by researchers affiliated with a collagen research institute.

Is UC-II the same thing as collagen peptides?

No. Undenatured type II collagen (UC-II) is studied at 40 mg per day, roughly 250 times smaller than the 10 g per day used in joint trials of hydrolyzed collagen. It is proposed to work through immune tolerance rather than by supplying building blocks. Evidence for one does not transfer to the other.

Does a lower molecular weight collagen work better?

The human evidence does not establish this. Only one randomized trial with clinical endpoints appears to have compared molecular weights, in people with pressure ulcers. It also varied dipeptide content between the arms and never compared the arms head to head, so molecular weight cannot be isolated. In a small pharmacokinetic study of nine people, ordinary gelatin hydrolysate did not significantly beat plain gelatin on one key dipeptide. The authors concluded gelatin is useful as a functional food as effectively as gelatin hydrolysate.

How much collagen should I take and for how long?

In the trials I verified, skin studies commonly used 2.5 to 5 g per day for 8 to 12 weeks, with meta-analyses emphasizing about 90 days. Higher intakes of around 10 g per day are reported elsewhere. Joint trials of hydrolyzed collagen used about 10 g per day for 24 weeks. UC-II used 40 mg per day for 180 days. The bone trial used 5 g per day for 12 months. The uncontrolled nail study used 2.5 g per day for 24 weeks. This describes what was studied. It is not a dosing recommendation.

Is marine collagen better than bovine?

I could not find a primary source that supports the popular species-to-type shorthand. A 2019 review names bovine, porcine, ovine, chicken, duck, rabbit, fish and jellyfish as sources of hydrolyzed collagen. Separately, it notes that type I predominates in skin and bone while type II is the cartilage collagen. It does not map species to types. No head-to-head human trial of marine against bovine collagen surfaced in my searches. I have not investigated whether sourcing risks differ materially by species.

Are collagen supplements FDA approved?

No, and no dietary supplement is. Under DSHEA the FDA has no authority to approve dietary supplements before they are marketed, and generally does not approve supplement claims or labeling before use. Structure and function claims require the disclaimer that the product is not intended to diagnose, treat, cure or prevent any disease. The firm, not the FDA, must hold the substantiation. A label saying FDA-registered facility says nothing about whether the product works.

References (14 sources)

Bibliographic detail is fetched from PubMed, not written by me - so a citation here cannot drift from the paper it names. Study design comes from PubMed's own tags rather than my judgement.

  1. 1.Sato K. The presence of food-derived collagen peptides in human body-structure and biological activity. Food Funct. 2017;8(12):4325-4330.ReviewPMID 29114654
  2. 2.Hwang S, Won J, Kim S et al. Low-Molecular-Weight Collagen Peptide Supplementation Improves Cellulite Severity, Skin Elasticity, and Hair Shaft Diameter: A Clinical Study with Pharmacokinetic Evaluation. J Med Food. 2026;29(4):187-195.Randomised trialPMID 41788055
  3. 3.León-López A, Morales-Peñaloza A, Martínez-Juárez VM et al. Hydrolyzed Collagen-Sources and Applications. Molecules. 2019;24(22).ReviewPMID 31703345full text
  4. 4.de Miranda RB, Weimer P, Rossi RC. Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis. Int J Dermatol. 2021;60(12):1449-1461.Meta-analysisPMID 33742704
  5. 5.Proksch E, Segger D, Degwert J et al. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study. Skin Pharmacol Physiol. 2014;27(1):47-55.Randomised trialPMID 23949208
  6. 6.Nukaly HY, Halawani IR, Irtaza HM et al. Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). 2026;13:1618306.Systematic reviewPMID 41924746full text
  7. 7.Clark KL, Sebastianelli W, Flechsenhar KR et al. 24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain. Curr Med Res Opin. 2008;24(5):1485-96.Randomised trialPMID 18416885
  8. 8.Liu X, Machado GC, Eyles JP et al. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. Br J Sports Med. 2018;52(3):167-175.Meta-analysisPMID 29018060
  9. 9.Lugo JP, Saiyed ZM, Lane NE. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study. Nutr J. 2016;15:14.Randomised trialPMID 26822714full text
  10. 10.König D, Oesser S, Scharla S et al. Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women-A Randomized Controlled Study. Nutrients. 2018;10(1).Randomised trialPMID 29337906full text
  11. 11.Hexsel D, Zague V, Schunck M et al. Oral supplementation with specific bioactive collagen peptides improves nail growth and reduces symptoms of brittle nails. J Cosmet Dermatol. 2017;16(4):520-526.Clinical trialPMID 28786550
  12. 12.Sugihara F, Inoue N, Venkateswarathirukumara S. Ingestion of bioactive collagen hydrolysates enhanced pressure ulcer healing in a randomized double-blind placebo-controlled clinical study. Sci Rep. 2018;8(1):11403.Randomised trialPMID 30061579full text
  13. 13.Iwasaki Y, Nakatogawa M, Shimizu A et al. Comparison of gelatin and low-molecular weight gelatin hydrolysate ingestion on hydroxyproline (Hyp), Pro-Hyp and Hyp-Gly concentrations in human blood. Food Chem. 2022;369:130869.StudyPMID 34461513
  14. 14.FDA - Questions and Answers on Dietary Supplements- US Food and Drug Administrationregulatory